All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

Oregon State University Researchers Develop Iron Nanomaterial That Selectively Destroys Cancer Cells

By

gradus_ad

3mo ago· 3 min readenNews

Summary

Researchers at Oregon State University have developed a novel iron-based nanomaterial that targets and destroys cancer cells from within. The material exploits cancer cells' unique acidic environment and high hydrogen peroxide levels to trigger two simultaneous chemical reactions, generating oxidative stress that overwhelms and kills cancer cells while leaving healthy tissue unaffected. This advancement in chemodynamic therapy (CDT) represents a promising approach to cancer treatment with reduced side effects.

Key quotes

· 4 pulled
Researchers at Oregon State University have created a new nanomaterial designed to destroy cancer cells from the inside.
The material activates two separate chemical reactions once inside a tumor cell, overwhelming it with oxidative stress while leaving surrounding healthy tissue unharmed.
Designed to exploit cancer's unique chemistry—its acidity and high hydrogen peroxide levels—the tiny iron-based structure sparks not one but two intense chemical reactions, flooding tumors with cell-damaging oxygen molecules.
This dual attack overwhelms cancer cells with oxidative stress while sparing healthy tissue.
Snippet from the RSS feed
Scientists at Oregon State University have engineered a powerful new nanomaterial that zeroes in on cancer cells and destroys them from the inside out. Designed to exploit cancer’s unique chemistry—its acidity and high hydrogen peroxide levels—the tiny ir

You might also wanna read

Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds

Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a

npr.org·55m ago

Spinach-derived photosynthetic treatment shows promise for dry eye disease

Scientists at the National University of Singapore have developed an experimental treatment for dry eye disease that uses photosynthetic mac

biotechniques.com·2h ago

Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1

Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus

biozentrum.unibas.ch·3h ago

Exploring the science behind quantum effects in healthcare: separating research from pseudoscience

The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg

newscientist.com·8h ago

Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial

A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug

chicagotribune.com·8h ago

Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial

A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug

chicagotribune.com·8h ago